Unlocking new potential: Rationale and evidence for dual EZH2/AR inhibition in mCRPC

Personalizing cataract surgery: From pre-operative precision to functional vision outcomes

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with a leading expert in cataract surgery. Dr Filomena Ribeiro shares insights on the latest advances in pre-operative assessment, AI-enhanced IOL power calculation and functional depth-of-field (DOFi)-based lens selection, as well as emerging IOL materials and technologies. She also provides practical guidance on patient communication strategies to support consistent, patient-centred refractive outcomes. The expert: * Dr Filomena Ribeiro, Hospital da Luz Lisboa, University of Lisbon and Catholic University of Portugal, Lisbon, Portugal This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Alcon Eye Care UK Limited. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchophthalmologyime.org/personalizing-cataract-surgery-from-pre-op-precision-to-functional-vision-outcomes/ [https://touchophthalmologyime.org/personalizing-cataract-surgery-from-pre-op-precision-to-functional-vision-outcomes/]

Cracking the code of CIDP: Mastering diagnostic precision

touchCASES for touchNEUROLOGY Listen to two US-based experts as they discuss how to improve diagnostic accuracy in the USA for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). They will discuss three patient cases to illustrate how to recognize and differentiate CIDP variants from other polyneuropathies, and apply key diagnostic criteria to help strengthen a diagnosis. The experts: * Dr Karissa Gable, Duke University, Durham, NC, USA * Dr Jeffrey Allen, University of Minnesota, Minneapolis, MN, USA This activity is funded by an independent medical education grant from Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME. This activity is for HCPs in the USA only. For further information, visit our website: https://touchneurologyime.org/cidp-diagnostics/ [https://touchneurologyime.org/cidp-diagnostics/]

Looking beyond VEGF to target BRB dysfunction in DME: Novel approaches to prevent vision loss

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Dr. Diana Do as she shares her expert insights into the epidemiology and quality‑of‑life burden of diabetic macular edema (DME) in the USA, outlines real‑world limitations of current anti‑VEGF–based management, and examines emerging therapies that specifically target blood–retinal barrier (BRB) dysfunction and aim to provide more durable vision protection. The expert: * Dr. Diana Do, Stanford University School of Medicine, Palo Alto, CA, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchOPHTHALMOLOGY.com [http://www.touchophthalmology.com]

Unlocking new potential: Rationale and evidence for dual EZH2/AR inhibition in mCRPC

touchTALKS for touchONCOLOGY Listen to Dr Teresa Alonso-Gordoa, as she evaluates the latest data on dual EZH2/AR inhibition in mCRPC and explores how emerging evidence could influence clinical decision-making in the future. The expert * Dr. Teresa Alonso-Gordoa - Hospital Universitario Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Pfizer. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.  For further information visit our website: www.touchONCOLOGY.com [http://www.touchoncology.com]

Integrating neurosensory pathway insights into modern dry eye management

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with three leading experts discussing neural-targeted therapies for dry eye disease (DED). The faculty describe the neuronal control of tear secretion, explore the mechanisms of action and clinical findings with neuromodulatory/neurostimulatory therapies for DED, and discuss how to integrate these therapies into personalized treatment plans. The experts: * Dr Anat Galor – Bascom Palmer Eye Institute, Miami, USA * Dr Christopher Starr – Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, USA * Dr Marjan Farid – University of California Irvine Medical Center, Irvine, USA This touchPODCAST is for healthcare professionals in the USA, Canada and Latin America This activity is funded by an independent medical education grant from Alcon Vision LLC. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchophthalmologyime.org [https://touchophthalmologyime.org/]